DAIICHI SANKYO, INC. for DAIICHI SANKYO INC
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Discussions regarding H.R.5539, the ORPHAN Cures Act Discussions related to H.R.4534 - the Women and Lung Cancer Research and Preventive Services Act Discussions related to H.R.5391 - the Protecting Patient Access to Cancer and Complex Therapies Act 340B reform generally as well as H.R.8574 - the 340B ACCESS Act
Foreign entity interest: To the degree that public policies, either laws or regulations, commercially impact Daiichi Sankyo, Inc. so too, Daiichi Sankyo Co., LTD, the parent company, will likewise be impacted.
| Lobbyist | Covered position, as disclosed |
|---|---|
| AARON BILL | — |
| AMANDA PEZALLA | — |
Taxation/Internal Revenue Code TAX
Discussions regarding U.S. corporate tax issues
Foreign entity interest: To the degree that public policies, either laws or regulations, commercially impact Daiichi Sankyo, Inc. so too, Daiichi Sankyo Co., LTD, the parent company, will likewise be impacted.
| Lobbyist | Covered position, as disclosed |
|---|---|
| AARON BILL | — |
| AMANDA PEZALLA | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.